Cipla
Ankit Jangra is a seasoned professional in business development within the pharmaceutical industry, currently serving as Manager - Business Development for North America at Cipla since September 2023. Prior experience includes roles as Deputy Manager and Assistant Manager of Business Development at Recipharm from April 2020 to September 2023, where responsibilities encompassed contract manufacturing, commercial negotiation, and agreement execution. At Akums Drugs & Pharmaceuticals Ltd, Ankit focused on business development and portfolio management from August 2017 to April 2020, prioritizing the identification of in-licensing and joint venture opportunities in the pharma, nutraceuticals, and derma-cosmetic sectors across EU, US, and APAC. Ankit started professional career at Eli Lilly and Company as Senior Territory Manager for diabetes products, successfully launching Trulicity in North Delhi. Academic credentials include an MBA in Pharmaceutical Marketing and Management from the National Institute of Pharmaceutical Education and Research and a Bachelor of Pharmacy from Maharaja Surajmal Institute of Pharmacy.
This person is not in the org chart
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.